Oruka Therapeutics, Inc. · NASDAQ:ORKA

Quinlan Paul T sold 1,039 Oruka Therapeutics, Inc. shares (Form 4)

Traded Sep 15, 2026 · Filed Sep 15, 2026

On Sep 15, 2026, Quinlan Paul T (General Counsel) sold 1,039 Oruka Therapeutics, Inc. shares at US$95.71 for US$99,443, leaving 29,995 shares. Filed Sep 15, 2026 (Form 4).

Sold
1,039 shares
Price
US$95.71
Value
US$99,443
Holding after
29,995 shares
Trading plan
No
Role
General Counsel

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common StockSale1,039US$95.7129,995Direct

Source

View original at SEC

Related